Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Cents and Sensibility - Kimberly and Friends' Consortium -- Ignore unavailable to you. Want to Upgrade?

To: StoxRider who wrote (61645)	1/12/2000 6:38:00 PM
From: $Mogul	Read Replies (5) \| Respond to of 108040

ISIP- Yeah the current price is a joke. That Re-iteration should make shorts very scared. $40-$50 and the stock is at $10... and has immense volume..yeah I would think there will be a short squeeze in the coming days. Princeton, New Jersey, Jan. 7 (Bloomberg Data) -- Isis Pharmaceuticals Inc. (ISIP US) was reiterated short-term ``outperform' by analyst Jeffrey J. Kraws at Gruntal & Co. The long-term rating was also reiterated 'outperform.' The short-term and long-term price targets are $43 and $52 per share, respectively.